Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 131, Issue 3, Pages -
Publisher
American Society for Clinical Investigation
Online
2020-12-11
DOI
10.1172/jci144893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
- (2020) Silvia Lanfranconi et al. Trials
- Novel Murine Models of Cerebral Cavernous Malformations
- (2020) Matthew R. Detter et al. ANGIOGENESIS
- Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease
- (2019) Robert Shenkar et al. STROKE
- Endothelial cell clonal expansion in the development of cerebral cavernous malformations
- (2019) Matteo Malinverno et al. Nature Communications
- R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma
- (2019) Jeroen Overman et al. eLife
- A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
- (2019) Lisa McKerracher et al. Translational Stroke Research
- Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study
- (2018) Johannes Goldberg et al. JOURNAL OF NEUROSURGERY
- Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells
- (2018) Matthew R. Detter et al. CIRCULATION RESEARCH
- B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models
- (2016) Changbin Shi et al. Journal of Neuroimmune Pharmacology
- Propranolol stops progressive multiple cerebral cavernoma in an adult patient
- (2016) Matthias Reinhard et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Medical management of vascular anomalies
- (2016) Cameron C Trenor SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations
- (2014) Robert Shenkar et al. GENETICS IN MEDICINE
- Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol
- (2014) Juliette Miquel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio)
- (2012) Juliane Finn et al. AQUATIC TOXICOLOGY
- Infantile intraspinal and extensive cutaneous hemangiomas: Excellent response to propranolol
- (2011) P. S. Ghosh et al. NEUROLOGY
- Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease
- (2011) David A. McDonald et al. STROKE
- Propranolol Treatment for a Giant Infantile Brain Cavernoma
- (2010) Maria Moschovi et al. JOURNAL OF CHILD NEUROLOGY
- Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
- (2010) Rebecca A. Stockton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation
- (2009) Zhipeng Wang et al. GENE
- Biology of Vascular Malformations of the Brain
- (2009) Gabrielle G. Leblanc et al. STROKE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started